Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
12/18/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals added to the NASDAQ Biotechnology Index (NBI)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/17/201812:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/17/201812:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/29/20184:35PMPR Newswire (US)AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/19/20186:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20186:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20184:05PMPR Newswire (US)AcelRx Pharmaceuticals to Present at the 17th Annual ASRA Pain Medicine MeetingNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/13/20185:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/13/20185:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/13/20181:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20189:10AMPR Newswire (US)AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20187:07AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/07/20185:19PMPR Newswire (US)AcelRx Pharmaceuticals to Present at Credit Suisse 27th Annual Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20185:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20185:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20185:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20185:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20185:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/05/20189:25AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/02/20184:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/02/20184:05PMPR Newswire (US)AcelRx Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/02/20183:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/02/20181:56PMPR Newswire (US)AcelRx announces FDA approval of DSUVIAâ„¢NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/19/20183:15PMPR Newswire (US)AcelRx Provides Updated Comments Following Positive FDA Advisory Committee MeetingNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/16/20184:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/16/20184:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/15/20184:01PMPR Newswire (US)DSUVIA Efficacy and Safety Data to be Presented at the American Society of Anesthesiologists (ASA) Annual ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/12/20184:15PMPR Newswire (US)FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute PainNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/12/20187:10AMPR Newswire (US)AcelRx Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review DSUVIA New Drug ApplicationNASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX